Mutations in the RMND1 gene, causing defects in the mitochondrial respiratory chain, result in a very heterozygous phenotype. Currently there are 36 cases reported in the literature. We report two siblings from a non-consanguineous family who were severely affected by a compound heterozygous RMND1 mutation that had not been described previously and were treated differently for their end-stage renal disease. We summarize all previous published cases and focus on the importance of extrarenal comorbidities in the context of therapeutic decision making (renal replacement therapy) and its ethical relevance.
Keywords: Chronic kidney disease; Ethical issues and children; Mitochondrial disease; RMND1 gene; Renal hypoplasia.
Copyright © 2019 French Society of Pediatrics. Published by Elsevier Masson SAS. All rights reserved.